REGEN BIOPHARMA, INC. (RGBPP) Operating cash flow 2016–2025
REGEN BIOPHARMA, INC. (RGBPP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$383,591FY2025 · since FY2016: -$1.7M → -$383,591
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$383,591 | +49.0% |
| FY2024 | -$751,536 | -332.1% |
| FY2023 | -$173,917 | +71.3% |
| FY2022 | -$606,921 | +46.3% |
| FY2021 | -$1.1M | -6165.6% |
| FY2020 | $18,645 | +103.9% |
| FY2019 | -$481,792 | +69.5% |
| FY2018 | -$1.6M | +16.7% |
| FY2017 | -$1.9M | -13.3% |
| FY2016 | -$1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice